Approval · Notice of Compliance 5523 · 1994
SULCRATE: Notice of Compliance 5523
Issued June 15, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5523
- Date
- June 15, 1994
- Company
- Marion Merrell Dow (Canada) Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Gastro-duodenal cytoprotective agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SULCRATE | 02100622 | Marketed |
| SULCRATE SUSPENSION PLUS | 02103567 | Marketed |
Medicinal ingredients
- SUCRALFATE 1 G per TAB
- SUCRALFATE 1 G per 5ML